MIL:AMP
Amplifon S.p.A. · MIL · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-07 14:34 UTC
Last close
n/aEUR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
29.3xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
3.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
12.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.4%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Safety is the furthest below its sector's middle: 0.30 against 0.53 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.32x
Its own average over 10 years, 1.82B.
- Profit0.76x
Its own average over 10 years, 120.2M.
- Free cash flow1.20x
Its own average over 10 years, 246.6M.
- Debt1.42x
Its own average over 10 years, 1.28B.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 1.42 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 111.7 | 158.1 | 99.8 |
| 2018-12-31 | 120.2 | 157.9 | 99.6 |
| 2019-12-31 | 152.9 | 170.8 | 100.3 |
| 2020-12-31 | 137.3 | 158.8 | 100.7 |
| 2021-12-31 | 171.9 | 248.0 | 101.0 |
| 2022-12-31 | 187.0 | 280.6 | 100.8 |
| 2023-12-31 | 199.5 | 243.9 | 100.2 |
| 2024-12-31 | 212.6 | 228.5 | 100.1 |
| 2025-12-31 | 211.4 | 143.6 | 97.7 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Figures behind the shape
Growth
9.0%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate9.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Five-year EPS growth rate-1.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
One-year change in net income-37.2%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Returns on capital
9.2%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity9.2%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets2.4%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
8.8%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin8.8%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin8.6%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin3.8%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin12.4%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
29.3xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings29.3x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
Price to book2.7x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio1.1x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.59safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio0.59
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage3.4x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score1.58
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
2.4%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yield2.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Payout ratio71.5%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio4.5x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.